Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2020 | Exciting updates from SABCS 2020

Sibylle Loibl • 10 Dec 2020
SABCS 2020
Breast Cancer
MONALEESA monarchE

Sibylle Loibl, MD, PhD, German Breast Group, Neu-Isenburg, Germany, outlines exciting updates presented at this years’ San Antonio Breast Cancer Symposium (SABCS) including the results of the monarchE study (NCT02107703) as well as combined analysis of the MONALEESA study (NCT01958021). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Sibylle Loibl

1:28
Long-term survival of the Phase II GeparOLA study
Sibylle Loibl • 6 Dec 2022
0:36
Maintenance w/ ET + ribociclib after 1L chemotherapy in HR+/HER2- metastatic breast cancer
Sibylle Loibl • 6 Dec 2022
1:43
Composite biomarkers predictive of palbociclib + endocrine treatment benefit in early breast cancer
Sibylle Loibl • 6 Dec 2022
1:03
Key takeaways from SABCS 2022
Sibylle Loibl • 6 Dec 2022

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:03
The future of peptide-conjugated drugs in oncology
Mitchell Elliott • 8 Apr 2024
1:26
The clinical applications of MRD in breast cancer
Mitchell Elliott • 8 Apr 2024
1:47
CCNG1 as a biomarker for DRG-101 gene therapy in cancer
Vaishali Kumar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals